Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jul 17 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-1.13 Insider Own10.38% Shs Outstand15.81M Perf Week-0.35%
Market Cap45.53M Forward P/E- EPS next Y-0.39 Insider Trans0.00% Shs Float14.17M Perf Month-6.80%
Income-6.89M PEG- EPS next Q-0.10 Inst Own6.03% Short Float1.12% Perf Quarter24.68%
Sales0.34M P/S133.92 EPS this Y60.07% Inst Trans8.21% Short Ratio0.76 Perf Half Y85.81%
Book/sh0.64 P/B4.50 EPS next Y2.48% ROA-95.89% Short Interest0.16M Perf Year275.78%
Cash/sh0.54 P/C5.35 EPS next 5Y- ROE-101.53% 52W Range0.72 - 6.85 Perf YTD130.40%
Dividend Est.- P/FCF- EPS past 5Y18.43% ROI-67.33% 52W High-57.96% Beta1.03
Dividend TTM- Quick Ratio58.27 Sales past 5Y9.26% Gross Margin42.24% 52W Low300.00% ATR (14)0.29
Dividend Ex-Date- Current Ratio58.27 EPS Y/Y TTM6.34% Oper. Margin-2024.38% RSI (14)49.85 Volatility10.56% 9.65%
Employees5 Debt/Eq0.01 Sales Y/Y TTM94.44% Profit Margin-2022.66% Recom1.00 Target Price10.00
Option/ShortNo / Yes LT Debt/Eq0.01 EPS Q/Q41.04% Payout- Rel Volume1.47 Prev Close2.97
Sales Surprise- EPS Surprise40.00% Sales Q/Q139.90% EarningsApr 09 Avg Volume209.64K Price2.88
SMA204.71% SMA50-7.32% SMA20025.83% Trades Volume307,994 Change-3.03%
Jul-17-24 10:30AM
Jul-16-24 09:20AM
Jul-12-24 05:52PM
Jul-09-24 09:10AM
Jul-08-24 09:10AM
06:40AM Loading…
Jun-24-24 06:40AM
Jun-18-24 09:00AM
Jun-14-24 07:15AM
Jun-05-24 09:00AM
Jun-04-24 07:28AM
May-30-24 06:45AM
May-23-24 09:05AM
May-21-24 09:20AM
May-17-24 09:10AM
May-08-24 09:10AM
09:05AM Loading…
May-06-24 09:05AM
Apr-30-24 03:40PM
Apr-16-24 09:10AM
Apr-09-24 09:52PM
Apr-02-24 09:00AM
Mar-21-24 09:20AM
Mar-14-24 09:20AM
Mar-07-24 09:05AM
Mar-05-24 09:05AM
Mar-04-24 09:15AM
Mar-01-24 08:20AM
Feb-16-24 04:05PM
Feb-15-24 08:00AM
Jan-30-24 08:45AM
Jan-24-24 08:45AM
08:51AM Loading…
Jan-22-24 08:51AM
Jan-16-24 09:10AM
Jan-11-24 08:30AM
Jan-10-24 08:30AM
Jan-09-24 08:30AM
Jan-08-24 08:30AM
Jan-04-24 09:05AM
Dec-07-23 09:20AM
Nov-28-23 09:10AM
Nov-27-23 09:05AM
Nov-01-23 08:30AM
Oct-31-23 08:31AM
Oct-30-23 09:30AM
Oct-13-23 09:05AM
Oct-12-23 09:10AM
Sep-29-23 08:00AM
Sep-21-23 09:10AM
Aug-30-23 09:20AM
Aug-28-23 09:02AM
Aug-23-23 11:12AM
Aug-09-23 09:15AM
Aug-02-23 09:10AM
Jul-28-23 09:10AM
Jul-19-23 09:05AM
Jun-26-23 07:47AM
Jun-22-23 09:25AM
Jun-20-23 09:05AM
Jun-16-23 09:10AM
Jun-12-23 09:20AM
May-23-23 09:05AM
May-18-23 04:22PM
May-11-23 01:45PM
May-10-23 10:15AM
May-08-23 08:35PM
Apr-24-23 09:00AM
Apr-20-23 09:00AM
Mar-07-23 05:54AM
Mar-02-23 08:45AM
Feb-21-23 02:41PM
Jan-31-23 08:30AM
Jan-23-23 08:45AM
Jan-17-23 08:33AM
Jan-13-23 04:05PM
Dec-29-22 09:00AM
Dec-21-22 09:00AM
Dec-20-22 12:35PM
Nov-30-22 05:24AM
Nov-29-22 08:50AM
Nov-21-22 09:19AM
Nov-10-22 09:20AM
Nov-08-22 09:10AM
Nov-01-22 09:25AM
Oct-31-22 05:26AM
Oct-27-22 08:45AM
Sep-20-22 08:30AM
Sep-02-22 09:15AM
Aug-31-22 09:05AM
Aug-11-22 09:15AM
Aug-10-22 10:36AM
Aug-09-22 08:30AM
Aug-03-22 09:45AM
Lexaria Bioscience Corp. is a biotechnology company, which engages in the provision of active pharmaceutical ingredients through its DehydraTECH drug delivery technology. Its products can be used with APIs fat-soluble vitamins, non-steroidal anti-inflammatory drugs (NSAIDs) pain medications, hormones, phosphodiesterase inhibitors, antivirals, nicotine and its analogs, and all cannabinoids including tetrahydrocannabinol (THC) for therapeutic indications, as well as hypertension, SARS-CoV-2/COVID-19, and HIV/AIDS. It operates through the following segments: IP Licensing, B2B Product, Research and Development, and Corporate. The company was founded on December 9, 2004 and is headquartered in Kelowna, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Carle VanessaSecretaryMay 14 '24Option Exercise1.152,5002,8752,567May 15 05:37 PM